Agios Pharmaceuticals Inc (AGIO)
Cost of Revenue
$11.88M
TTM · Period ending: · USD
AGIO Cost of Revenue
Latest reported$11.88Mperiod ending
Latest reported$11.88Mperiod ending
AGIO TTM Cost of Revenue ($21.02M → $11.88M)
TTM cost of revenue
High-resolution chart · PNG
AGIO cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 11,876,000 | |
| 11,841,000 | |
| 11,522,000 | |
| 9,637,000 | |
| 7,367,000 | |
| 7,494,000 | |
| 7,106,000 | |
| 7,835,000 | |
| 7,685,000 | |
| 10,167,000 | |
| 13,144,000 | |
| 15,945,000 | |
| 20,323,000 | |
| 19,962,000 | |
| 20,263,000 | |
| 20,083,000 | |
| 19,650,000 | |
| 19,134,000 | |
| 18,777,000 | |
| 15,126,000 | |
| 11,186,000 | |
| 7,168,000 | |
| 2,805,000 | |
| 2,133,000 | |
| 1,888,000 | |
| 1,516,000 | |
| 1,317,000 | |
| 1,732,000 | |
| 2,034,000 | |
| 88,461,000 | |
| 166,351,000 | |
| 242,865,000 | |
| 315,087,000 | |
| 308,173,000 | |
| 292,681,000 | |
| 280,143,000 | |
| 267,869,000 | |
| 238,857,000 | |
| 220,163,000 | |
| 192,418,000 | |
| 167,803,000 | |
| 153,422,000 | |
| 141,827,000 | |
| 139,756,000 | |
| 129,254,000 | |
| 115,407,000 | |
| 100,371,000 | |
| 80,788,000 | |
| 70,065,000 | |
| 60,447,000 | |
| 54,502,000 | |
| 50,448,000 | |
| 45,443,000 | |
| 32,485,000 | |
| 21,023,000 |